MedTrace Logo

Treating Negative Mental Images and Memories in Social Anxiety

NCT03140839 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 33

Last updated 2019-01-16

No results posted yet for this study

Summary

The proposed research will study the effects of Imaginal Rescripting (IR) for social anxiety disorder (SAD). IR guides patients to change their memories of past socially painful events. Initial studies have found that a single session of IR significantly reduces SAD symptoms, however it is not yet clear how or why IR works and whether its effects are long lasting. To answer these questions, the investigators will randomly assign adults with SAD to receive either IR, or two other types of brief psychological interventions: Imaginal Exposure and Supportive Counselling. Changes in participants' memories, social anxiety symptoms, quality of life, negative beliefs, and social behaviour over the course of a 6-month period will be assessed. This study will provide valuable insight into the short- and long-term effects of IR and clarify the mechanisms through which IR works. Ultimately, this knowledge will enable the development of more effective treatments and prevention programs for SAD.

Conditions

  • Social Anxiety

Interventions

BEHAVIORAL

Imaginal Rescripting

A stand-alone single session intervention for social anxiety disorder

BEHAVIORAL

Imaginal Exposure

A stand-alone single session intervention for social anxiety disorder

OTHER

Supportive Counselling

Non-specific talk therapy focused on non-directive and empathic listening and on supporting patients' existing coping skills and strategies.

Sponsors & Collaborators

  • Hebrew University of Jerusalem

    collaborator OTHER

  • University of Toronto

    collaborator OTHER

  • Baycrest

    collaborator OTHER

  • University of Waterloo

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-05-10
Primary Completion
2018-08-23
Completion
2018-08-23

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03140839 on ClinicalTrials.gov